Company Filing History:
Years Active: 1984-1993
Title: Dana Brooke: Innovator in Pharmaceutical Compositions
Introduction
Dana Brooke is a notable inventor based in Evansville, IN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 3 patents, her work has had a meaningful impact on the industry.
Latest Patents
Dana Brooke's latest patents include groundbreaking advancements in drug compositions. One of her notable inventions is the lyophilized ifosfamide compositions. This patent describes improved lyophilizate compositions of ifosfamide that utilize urea as the primary excipient. The modified freeze-drying process she developed results in products with increased heat stability and an extended shelf storage life. Another significant patent is for a sustained release tablet containing at least 95 percent theophylline. These non-disintegrating theophylline tablets feature a pair of opposing substantially planar surfaces and a very thin cross-section. They offer high bioavailability upon ingestion and a steady release rate, allowing for a 12-hour dosing interval to maintain non-toxic therapeutic blood theophylline concentrations.
Career Highlights
Throughout her career, Dana has worked with prominent companies such as Mead Johnson & Company and Bristol-Myers Squibb Company. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.
Collaborations
Dana has collaborated with notable individuals in her field, including Stephen T. David and Claude E. Gallian. These partnerships have further enriched her work and expanded her contributions to pharmaceutical research.
Conclusion
Dana Brooke is a distinguished inventor whose work in pharmaceutical compositions has led to significant advancements in drug formulation. Her innovative patents and collaborations highlight her commitment to improving therapeutic options for patients.